Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cell metabolism encompasses the altered metabolic pathways and reprogramming that occur in cancer cells to support their uncontrolled growth, survival, proliferation, and adaptation. Key features include aerobic glycolysis (Warburg effect), altered mitochondrial function, increased glutaminolysis, enhanced lipid metabolism, and upregulated one-carbon metabolism. These changes are driven by oncogenic mutations, tumor suppressor loss, and activation of signaling pathways like PI3K-mTOR, resulting in sustained proliferation, resistance to apoptosis, and enhanced invasion/metastasis. Targeting cancer cell metabolism is a promising therapeutic strategy, but challenges include potential toxicity and the development of resistance.
Varies depending on the specific metabolic pathway or enzyme targeted, but generally involves inhibiting key metabolic enzymes or pathways to disrupt energy production, biosynthesis, or redox balance in cancer cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer Cell Metabolism.